News

The next generation Watchman device is designed to better seal off complex LAA anatomy to prevent strokes in atrial fibrillation patients. It uses an optimized architecture to fill gaps and adapt to the unique characteristics of each patient's appendage, which come in a wide variety of shapes and sizes.

The next generation Watchman device is designed to better seal off complex LAA anatomy in a variety of LAA shapes and sizes.

Thumbnail

Healthcare's cost-conscious environment prompted the ACC and AHA to develop a statement on the value methodology to be used when creating clinical practice guidelines.

The Artero peripheral electric IVL (E-IVL) system is about to enter its US FDA IDE trial.

"The key question isn't just whether a device works, but whether it makes procedures more efficient and provides physicians with a more predictable tool for treating patients with complex arterial disease," explained co-principal investigator Venita Chandra, MD, clinical professor of surgery at Stanford Health Care.

Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, director of prevention, associate director, Barbra Streisand Women's Heart Center, Cedars-Sinai, and past president of the American Society for Preventive Cardiology (ASPC), was co-chair on a new joint scientific statement from the Heart Failure Society of America, and the ASPC on the need to boost prevention efforts for heart failure. She explains the new scientific statement that calls for greater prevention efforts in heart failure.

Martha Gulati, MD, co-chair on a new joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology, discusses the dire need she sees to boost prevention efforts for heart failure.

 

SCAI says many children and adults living with congenital heart disease are being left behind by a payment system that does not adequately value their care.

mammogram mammography breast cancer

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Yes, even frail HFpEF patients see significant benefits when treated with semaglutide. Researchers believe these new data may help ease the minds of cardiologists everywhere.

Evinacumab-dgnb is sold by Regeneron under the brand name Evkeeza

Evinacumab-dgnb, sold by Regeneron under the brand name Evkeeza, can now be used to treat homozygous familial hypercholesterolemia in much younger patients.

Video interview with Anders Gilberg, MGA, senior vice president, government affairs at Medical Group Management Association (MGMA), explains the issues involved with the Affordable Care Act (ACA) subsidies that are set to end in late 2025 and what the impact will be on hospitals.

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.

Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology (ASNC) annual meeting, director of nuclear cardiology and a professor of medicine at Cleveland Clinic, spoke at a session on the role of cardiac imagers on the heart team. #ASNC

Heart teams continue to play a major role at hospitals and health systems all over the world. Cardiac imagers who have trained in multiple modalities can provide those teams with a significant amount of value.

The U.S. Food and Drug Administration (FDA) cleared a smart watch artificial intelligence (AI) algorithm that tells wearers if they are suspected of having hypertension, which is expected to help notify about 1 million users over the next year. This a is a new feature of the newly launched Apple Watch Ultra 3, which the company unveiled Sept. 9. Apple gained FDA for its Cardiovascular Machine Learning-Based Notification Software Hypertension Notification Feature (HTNF) Sept. 11, 2025.

The FDA’s decision arrived just days after Apple announced the new feature. "This tool empowers patients and clinicians to work together, putting prevention at the center of care," one cardiologist told Cardiovascular Business. 

Thumbnail

Safety concerns with certain Boston Scientific leads have resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August. 

Around the web

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.